The ‘Monster‘ of Tuberculosis: A Walkthrough Sharma Kinshuk, Hameed Saif, Khurana S.M.P., Fatima Zeeshan* Amity Institute of Biotechnology, Amity University, Haryana, Gurgaon (Manesar)-122413 *Corresponding Author Email: zfatima@ggn.amity.edu, drzeeshanfatima@gmail.com
Online published on 2 September, 2013. Abstract Tuberculosis (TB) is a deadly and epidemic disease of world despite the fact that global distribution of TB is not even. About, one-third of the population world-wide is infected by TB. Moreover, treatment of TB has become limited because of the arrival of resistance towards present therapeutics i.e. Multi Drug Resistant-TB (MDR-TB), Extensively Drug Resistant-TB (XDR-TB), Totally Drug Resistant-TB (TDR-TB) and which is further complicated by ever increasing HIV-TB related cases. Apart from these problems such as lack of proper and adequate diagnosis technique makes the problem still out of control. This article mainly focuses on recent updates on the current status of deadly disease TB, present available diagnostics, current treatment regimes and problems associated with TB. Top Keywords Tuberculosis, Mycobacterium tuberculosis, Multi-drug resistance, DOTS, Anti-TB drugs. Top |